droplet microfluidics
10x Genomics Lowers Onboarding Costs for Labs to Get Into Single-Cell Projects With New Platform
Premium
The new Chromium Xo, launched earlier this month, only runs the firm's latest 3' gene expression assay and has a list price of $25,000.
The company is also preparing to raise a Series A financing round to establish its technology in other application areas.
Atrandi Biosciences Raises $4.8M to Advance Commercialization of Single-Cell Microfluidics Tech
The company, formerly called Droplet Genomics, will apply the funds to establish a US customer support team and to advance commercialization of its droplet-based platforms.
The method is available as a service from Single Cell Discoveries, and the researchers behind it are exploring several avenues of commercialization.
Droplet Genomics Debuts New Microfluidic Screening Platform, Touting Throughput, Flexibility
Premium
The Vilnius, Lithuania-based firm recently delivered its first instruments to customers, who are using it for a wide variety of applications.
Jul 30, 2021
Sep 11, 2020
10x Genomics Prices Upsized $440M Public Offering
Aug 31, 2020
Jun 2, 2020
May 11, 2020
10x Genomics Q1 Revenues Increase 34 Percent
Apr 23, 2020
Feb 18, 2020
10x Genomics Q4 Revenues Grow 49 Percent
Sep 12, 2019